A first-in-human study to evaluate the safety tolerability and performance of A/California/7/2009 (H1N1)- like vaccine coated Nanopatches in comparison to placebo coated Nanopatches and intramuscular injection of A/California/7/2009 (H1N1)-like vaccine.. Nanopatches will be delivered to skin using an applicator device (CAPD). The study involves healthy adults.

A first-in-human study to evaluate the safety tolerability and performance of A/California/7/2009 (H1N1)- like vaccine coated Nanopatches in comparison to placebo coated Nanopatches and intramuscular injection of A/California/7/2009 (H1N1)-like vaccine.. Nanopatches will be delivered to skin using an applicator device (CAPD). The study involves healthy adults.

Completed

Phase of Trial:
Phase I

Latest Information Update:13 Dec 2016

At a glance

Drugs
H1N1-like vaccine coated nanopatch (Primary)

Indications
Influenza A virus H1N1 subtype

Focus
Adverse reactions; First in man

Most Recent Events

10 Dec 2016
Status changed from recruiting to completed.

19 Jul 2016
New trial record

Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

Login
with a username/password associated to an account with a valid subscription